Reproductive immunology. Modulation of immune responses in pregnancy and effects on pregnancy outcome
PhD ceremony: Mr. J.R. Prins, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Reproductive immunology. Modulation of immune responses in pregnancy and effects on pregnancy outcome
Promotor(s): prof. J.G. Aarnoudse, prof. A.J.M. van Oosterhout, prof. S.A. Robertson
Faculty: Medical Sciences
Pregnancy is a unique immunological challenge in which an antigenically distinct fetus and placenta develop in the uterus of the mother. The complex mechanisms by which the fetus avoids rejection, despite expression of paternal antigens, still remain incompletely understood. Disturbances in maternal tolerance are implicated in infertility and reproductive pathologies. For most of these complications no cure has been found yet.
This thesis describes the role of several maternal immune cells and examines the influence of endogenous factors, such as cytokines, and exogenous factors, such as exposure to cigarette smoke and semen on the maternal immune system during pregnancy. Immune parameters were analysed in healthy and complicated pregnancies in both humans and mouse models.
Research showed that during pregnancy, the maternal immune system is regulated through different pathways to guarantee successful pregnancy outcome. Furthermore, the absence or failure of one of these mechanisms leads to a compensatory response of one of the other tolerance mechanisms which is probably necessary to guarantee a successful pregnancy outcome. Our work provides evidence for immunological changes in early pregnancy which lead to later complications. We suggest that during pregnancy several maternal factors, including endocrinal, immunological and environmental ones, will together influence the pregnancy outcome. The results generated in this thesis may provide clues for therapeutic strategies to strengthen immune tolerance in preparation for healthy pregnancy.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.